DE3886986D1 - Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens. - Google Patents

Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.

Info

Publication number
DE3886986D1
DE3886986D1 DE88106614T DE3886986T DE3886986D1 DE 3886986 D1 DE3886986 D1 DE 3886986D1 DE 88106614 T DE88106614 T DE 88106614T DE 3886986 T DE3886986 T DE 3886986T DE 3886986 D1 DE3886986 D1 DE 3886986D1
Authority
DE
Germany
Prior art keywords
glycoprotein
preparation
active ingredient
agent containing
immunosuppressive agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88106614T
Other languages
English (en)
Other versions
DE3886986T2 (de
Inventor
Hajime Tsunoo
Kousuke Kino
Akio Yamasita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Products Co Ltd filed Critical Meiji Milk Products Co Ltd
Application granted granted Critical
Publication of DE3886986D1 publication Critical patent/DE3886986D1/de
Publication of DE3886986T2 publication Critical patent/DE3886986T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/375—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Basidiomycetes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/823—Lower fungi, e.g. mold

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3886986T 1987-04-28 1988-04-25 Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens. Expired - Fee Related DE3886986T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10602587 1987-04-28

Publications (2)

Publication Number Publication Date
DE3886986D1 true DE3886986D1 (de) 1994-02-24
DE3886986T2 DE3886986T2 (de) 1994-08-11

Family

ID=14423100

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3886986T Expired - Fee Related DE3886986T2 (de) 1987-04-28 1988-04-25 Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.

Country Status (4)

Country Link
US (1) US5334704A (de)
EP (1) EP0288959B1 (de)
KR (1) KR880012765A (de)
DE (1) DE3886986T2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920010763B1 (ko) * 1990-12-04 1992-12-17 일양약품공업 주식회사 항종양 면역증강효과가 있는 단백다당체(g 009)
US6893641B2 (en) * 1999-10-12 2005-05-17 Chee-Keung Chung Ganoderma lucidum spores for treatment of autoimmune diseases
US6383799B1 (en) 1999-10-15 2002-05-07 Medmyco Ltd. Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
KR100858569B1 (ko) * 2000-01-12 2008-09-17 생명과학연구소 유겐가이샤 버섯으로부터의 생리활성 추출물 eem-s, 그의 제조 방법 및 의약
JP4896332B2 (ja) * 2000-01-31 2012-03-14 正 五井野 担子菌類とウコギ科植物の有効成分に基づく生理活性組成物
US6613754B1 (en) * 2000-09-22 2003-09-02 National Yang-Ming University Polysaccharide-based extract from ganoderma, pharmaceutical use thereof, and process for preparing the same
US20030054047A1 (en) * 2001-06-15 2003-03-20 Sanjiu Medical & Pharmaceutical Co., Ltd. Pharmaceutical composition for the treatment of viral infection
US7135183B1 (en) * 2001-08-06 2006-11-14 Academia Sinica Immuno-modulating antitumor activities of Ganoderma lucidum (Reishi) polysaccharides
US7687064B2 (en) * 2001-08-06 2010-03-30 Academia Sinica Methods and compositions associated with administration of an extract of Ganoderma lucidum
TWI351963B (en) * 2003-09-17 2011-11-11 Yeastern Biotech Co Ltd Fungal immunomodulatory protein (fip) prepared by
JP2008517100A (ja) * 2004-10-14 2008-05-22 アカデミア シニカ ＧａｎｏｄｅｒｍａＬｕｃｉｄｕｍの抽出物の投与に関連した方法及び組成物
TWI386220B (zh) * 2005-10-14 2013-02-21 Academia Sinica 真菌免疫刺激組合物及其用途
WO2007047021A1 (en) * 2005-10-14 2007-04-26 Academia Sinica Methods and compositions associated with administration of an extract of ganoderma lucidum
US7601808B2 (en) 2006-03-02 2009-10-13 World Bio-Tech Alliance Corporation Immunomodulatory protein cloned from ganoderma microsporum
WO2008036421A2 (en) * 2006-09-21 2008-03-27 Academia Sinica Reishi-mediated enhancement of human tissue progenitor cell adhesion and differentiation
US20080214442A1 (en) * 2006-09-21 2008-09-04 Alice Yu Anti-Viral Effect of an Extract of Ganoderma Lucidum
US7947283B2 (en) * 2007-08-30 2011-05-24 Wyntek Corporation Compositions and methods for treating psoriasis by Ganoderma lucidum (Reishi) polysaccharides
US7785600B2 (en) * 2007-08-30 2010-08-31 Wyntek Corporation Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides
CN101475632B (zh) * 2008-01-03 2012-01-04 张喜田 具有抗肿瘤作用的重组灵芝免疫调节蛋白及其药物制剂
US8071105B2 (en) * 2008-04-21 2011-12-06 Academia Sinica Reishi F3 sub fraction polysaccharides and methods of using same
JP5685381B2 (ja) * 2009-03-13 2015-03-18 Ｊｃｒファーマ株式会社 糖類の分析方法
US8476238B2 (en) * 2010-06-29 2013-07-02 Mycomagic Biotechnology Co., Ltd. Uses of an immunomodulatory protein (GMI) from Ganoderma microsporum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1270765A (en) * 1969-07-14 1972-04-12 Taisho Pharmaceutical Co Ltd beta-1,3-LINKED POLYSACCHARIDES
JPS5775926A (en) * 1980-10-29 1982-05-12 Teikoku Chem Ind Corp Ltd Production of antitumor substance
JPS6056924A (ja) * 1983-09-09 1985-04-02 Ryoichi Ichihara 霊芝茶の製造方法

Also Published As

Publication number Publication date
KR880012765A (ko) 1988-11-29
EP0288959A3 (en) 1990-05-23
EP0288959A2 (de) 1988-11-02
EP0288959B1 (de) 1994-01-12
US5334704A (en) 1994-08-02
DE3886986T2 (de) 1994-08-11

Similar Documents

Publication Publication Date Title
DE3886986D1 (de) Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
DE3788244T2 (de) Pharmakologisch wirksame 3-substituierte 1,5-Diaryl-pyrazole und Verfahren zu ihrer Herstellung.
DE3868076D1 (de) Heterocyclische derivate, verfahren zu ihrer herstellung und diese derivate als aktive bestandteile enthaltende fungizide.
DE68909898D1 (de) Hochfester, Stickstoff enthaltender Cermet und Verfahren zu seiner Herstellung.
DE69006290D1 (de) N-Substituierte Benzyloxyiminderivate, Verfahren zu deren Herstellung und deren Verwendung.
DE69017479T2 (de) Azabicycloheptenderivate und ihre Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen.
DE3786390T2 (de) Arylaminopyrimidin-Derivate, Verfahren zu deren Herstellung und diese als wirksamen Stoff enthaltende Insektizide, Akarizide und Fungizide.
DE3788912D1 (de) Pyrimidin-Derivate, Verfahren zu deren Herstellung und diese als wirksamen Bestandteil enthaltende Pflanzenkrankheiten-Schutzmittel.
DE3863366D1 (de) Antibiotikum vermisporin, verfahren zu dessen herstellung und dasselbe als aktiver antibakterieller wirkstoff enthaltende pharmazeutische zusammensetzung.
DE3676148D1 (de) Antigerinnungsmittel, verfahren zu seiner herstellung und dieses mittel als wirkender grundstoff enthaltende antikoagulantia.
DE3881950D1 (de) Azabicyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3671451D1 (de) 4h-triazolo (4,3-a)(1,4) benzodiazepine, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
DE3853771T2 (de) Alkylaminopyrimidin-Derivate, Verfahren zu ihrer Herstellung und diese als aktive Bestandteile enthaltende Insektizide, Akarizide und Fungizide.
ATE56956T1 (de) (s)-(-)-1-propyl-2',6'-pipecoloxylididhydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
DE68908066T2 (de) Fluorchemische, oberflächenaktive Verbindungen und Verfahren zu deren Herstellung.
DE68919731D1 (de) Pyrimidin-Derivate, Verfahren zu deren Herstellung und diese enthaltende herbizide Zusammensetzungen.
DE3766299D1 (de) 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3852332D1 (de) 4-Thiochinazolin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen.
DE69021602D1 (de) N-substituierte-3-Hydrazino-benzenesulfonamid-Derivate, Verfahren zu ihrer Herstellung und herbizide Mittel.
DE3750029T2 (de) Cinnolin-Derivate, Verfahren zu deren Herstellung und diese enthaltende herbizide Zusammenstellung.
DE3877124D1 (de) Imidazol-derivate, verfahren zu deren herstellung und deren anwendung als alpha-2-adrenoceptor-antagonisten.
DE69019807T2 (de) Pyrimidindionderivate, Verfahren zu deren Herstellung und diese enthaltende antiarrhythmische Mittel.
DE69006071T2 (de) Bronchospasmolytische Verbindungen und Verfahren zu ihrer Herstellung.
DE69021127D1 (de) Polyisocyanatoalkylphenyl-isocyanurates, Verfahren zu deren Herstellung und deren Verwendung.
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee